0001209191-18-001276.txt : 20180103 0001209191-18-001276.hdr.sgml : 20180103 20180103182126 ACCESSION NUMBER: 0001209191-18-001276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180101 FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM GINGER L CENTRAL INDEX KEY: 0001192601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 18507376 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS, INC. STREET 2: 885 ARAPAHOE AVENUE CITY: BOULDER STATE: CO ZIP: 80302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-01 0 0001131324 GENOMIC HEALTH INC GHDX 0001192601 GRAHAM GINGER L 1108 NORTH LEMAY AVENUE FORT COLLINS CO 80524 1 0 0 0 Common Stock 2018-01-01 4 A 0 292 34.20 A 9739 I Held by the GInger L. Graham Revocable Trust Restricted stock issued to the Reporting Person pursuant to the Genomic Health, Inc. 2005 Stock Incentive Plan in lieu of quarterly director retainer fees. Restricted stock is fully vested. /s/ Jason W. Radford, Attorney-in-fact 2018-01-03